Icade share hits historic low at €14.23 and declines 2%
The office real estate company records a new absolute low during trading, in a declining Paris market. The stock briefly breached a threshold it had been defending for several days before recovering.
A new downside record at €14.23 in a retreating Paris market
The Icade share falls by 2.03% to €14.48 at mid-day and touched €14.23 during the session, a historic low. The previous record, at €14.26, dated from October 12. The stock also breached its support level at €14.42 before recovering above it, latest price at €14.46.
The RSI at 31.6 remains close to the oversold zone, following a 24.5% decline over three months. The CAC 40 is down 1.33% and the SBF 120 down 1.3% at the same time, while French debt remains under pressure: the 10-year OAT is at 4.79% according to the latest reading from the Banque de France, 1.37 points away from the Bund. Following weekend unrest, the Paris market is losing ground.
A busy financial calendar starting tomorrow, after a semester under pressure
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The real estate company publishes quarterly results on October 20. When publishing its first half 2026 accounts on July 21, it had confirmed its annual guidance, with the group's current net cash flow expected between €2.90 and €3.10 per share. Among the risks cited on that occasion were a 3.1% decline in asset values at constant scope and an increase in debt costs, expected around 2% by end of 2026.
Based on the consensus of reviewed analysts, the stock trades at approximately 4.9 times the expected earnings for the current financial year. Historically, Icade tends to move inversely to long-term euro zone rates, which places the security in a context of elevated yields. Next appointment: quarterly results on October 20.
Confirmation de la guidance annuelle 2026 avec un CFNC Groupe attendu entre 2,90 € et 3,10 € par action
Risks mentioned
Baisse de valeur du patrimoine de -3,1 % à périmètre constant, dont -2,8 % sur les bureaux
Réversion négative attendue sur les renouvellements de baux, potentiel de -7,1 % sur les loyers faciaux
Coût moyen de la dette en hausse à 1,85 %, attendu à environ 2 % fin 2026 ; ICR dégradé à 3,8x
Opportunities identified
Promesse de vente des actifs de santé au Portugal, environ 75 M€ en quote-part Icade
Acquisition des 49 % de la Tour Eqho avec un rendement supérieur à 8 %, relutive sur le CFNC
Réservations résidentielles en hausse de 11,9 % en volume et 6,4 % en valeur
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
